Our model can also be further refined to be a multimodal system capable of incorporating multiple staining features, which could be invaluable for subtyping cancers, such as BRCA, by concurrently assessing ER, PR, and HER2 IHC staining. The gene discussed is ERBB2; the disease is cancer.